Navigation Links
When is the right time to discuss delivery room research with parents?
Date:2/12/2014

ST. LOUIS For years, obtaining parental consent for clinical research regarding newborn resuscitation in the delivery room has been a challenge. Now, a Saint Louis University pediatric researcher is asking new mothers and pregnant women when doctors should seek parental permission to allow medical research related to delivery room treatments.

Marya Strand, M.D., associate professor of pediatrics at Saint Louis University, has received a $45,000 grant from the Fleur de Lis Fund of SSM Cardinal Glennon Children's Foundation to study the public opinion on obtaining consent. Through this study, Strand and her team will try to find the best time to ask mothers to sign a consent form in order for the baby to participate in a delivery room study.

"Much of how we treat babies in the delivery room has not been studied, it is just how we have always done it," Strand said. "Some of the treatments we use need to be studied to make sure we are providing the best care to newborns."

About 10 percent of all babies require resuscitation after they are born, but only a portion of that group will be eligible for individual research studies.

Traditionally, clinical studies about best practices to care for troubled newborns require the mother's approval shortly after delivery. She either signs a form that authorizes her baby to be part of a specific medical research study or a form that waives consent, which could allow her baby to be placed in the study researchers see as most appropriate.

"When we have to perform resuscitation for the baby in the delivery room, the mother is preoccupied with her own medical condition. Labor and delivery is a stressful time for parents and it's difficult for her to process the information about the procedure that will be performed on her baby," Strand said.

"It is even harder for the parents to weigh the risks and benefits of participating in a study. Through this current research, we want to develop a method of consent for clinical studies in the delivery room that satisfies the ethical requirements of the study but also makes it easier for the parents to understand what questions we are trying to answer through the research."

At any given time, neonatal care units have several ongoing clinical research trials in delivery room settings. Scientists need to enroll newborns who have problems at delivery into studies to determine the best practices to care for babies in the future.

For example, Strand's current research seeks the best way to treat a baby with meconium-stained amniotic fluid a condition in which a newborn can breathe a combination of fecal matter and amniotic fluid into the lungs at the time of delivery.

"Our standard treatment is to insert a breathing tube into the windpipe and suction whatever meconium might be there. But there are risks to doing this, and we know from other research that active babies don't benefit from this treatment," Strand said. "So, I would like to study that very select group of newborns: non-vigorous infants delivered through meconium-stained fluid."

But Strand's challenge in conducting her study is identifying those infants who would qualify to participate and getting consent from the parent at an emotionally charged time.

"Finding the appropriate time to talk to families about this question is tricky. One option is going to the obstetrician's office and collecting consent from as many mothers as possible who are at 36 weeks pregnant. But probably less than 2 percent of those mothers will deliver babies eligible for the study.

"So, should I introduce the possibility of complicated newborn care, resuscitation issues, possible respiratory failure, meconium aspiration syndrome and other problems that far before delivery? Is that fair to bring this worry to the mothers when they probably won't face this situation?" Strand said.

At this point, Strand says she doesn't know how moms will answer this question. Starting in February, Strand and her team will host eight focus groups, each with six to eight mothers either pregnant women or women who have delivered within six months prior and talk about the sticky issue of obtaining medical consent at an emotional time.


'/>"/>

Contact: Riya Anandwala
ranandwa@slu.edu
314-977-8018
Saint Louis University
Source:Eurekalert  

Related medicine news :

1. Opening Very Soon: Brightwater Senior Living of Highland - The Inland Empire's Newest Retirement, Assisted Living, and Memory Care Community
2. HealthWright Technologies Joins Wimbledon Health Partners National Team of Outside Sales Consultants
3. Winter Advisory: Ski Right - to Avoid Common Injuries!
4. Scientists make your stomach turn bright green if you have an ulcer
5. Start the New Year Rright With Delicious and Nutritious Meals from World Gardens Café
6. Donation by Best Drug Rehabilitation’s CEO Per Wickstrom to Help Detroit’s Cass Community Social Services (CCSS) Make the Holidays Brighter for Children
7. Federal Judge Fines Boehringer Ingelheim More Than $931K Due To Missing Evidence in Pradaxa Lawsuits Disturbs Wright & Schulte LLC
8. As Risperdal Lawsuits Move Forward, Wright & Schulte LLC Learns of Bid to Keep Clinical Studies Sealed in Pennsylvania Risperdal Litigation
9. Key Contribution from Melanie Nelson Fosters Health Rights on Two Continents
10. Are You Feeding Your Toddler Right? A New Pediatric Annals Study Provides Healthy Diet Suggestions
11. Parker Waichman LLP Reminds Whistleblowers of Their Rights under the False Claims Act as It Moves Forward with FedEx Lawsuit for Alleged Overcharging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
When is the right time to discuss delivery room research with parents?
(Date:3/29/2017)... , ... March 29, 2017 , ... Immunotherapy has emerged ... number of cancers and is touted to be the next revolution in our fight ... has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... The ... W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to ... deferred admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... SAN FRANCISCO , March 29, 2017 /PRNewswire/ ... an option agreement with Bionure Farma, S.L. for ... BN201 and to BN119 in the field of ... million plus sales-based royalties. The agreement provides ... stage assets with a differentiated product profile. Under ...
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
Breaking Medicine Technology: